Drug Profile
Amdoxovir - Advanced Antiviral Development Organization/Emory University/University of Georgia
Alternative Names: (-)-DAPD; beta-D-2-6-diaminopurine-dioxolane; DAPDLatest Information Update: 16 Jan 2019
Price :
$50
*
At a glance
- Originator Shire Pharmaceuticals Group
- Developer Advanced Antiviral Development Organization
- Class Antiretrovirals; Diamines; Dioxolanes; Purine nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 03 Aug 2015 No recent reports on development identified - Phase-II for HIV-1 infections (Combination therapy, Treatment-experienced) in Argentina (PO)
- 03 Aug 2015 No recent reports on development identified - Phase-II for HIV-1 infections in USA, Argentina (PO)